The webinar will provide an introduction to the framework for orphan drugs in Europe. SFL regulatory affairs experts will share their insights on opportunities and challenges for orphan drug designation and marketing authorization application for orphan drugs in the European Union, the United Kingdom and Switzerland. They will also provide insights into the revision of the EU orphan legislation.
